Science and Research

Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection

Streptococcus pneumoniae infections lead to high morbidity and mortality rates worldwide. Pneumococcal polysaccharide conjugate vaccines significantly reduce the burden of disease but have a limited range of protection, which encourages the development of a broadly protective protein-based alternative. We and others have shown that immunization with pneumococcal lipoproteins that lack the lipid anchor protects against colonization. Since immunity against S. pneumoniae is mediated through Toll-like receptor 2 signaling induced by lipidated proteins, we investigated the effects of a lipid modification on the induced immune responses in either intranasally or subcutaneously vaccinated mice. Here, we demonstrate that lipidation of recombinant lipoproteins DacB and PnrA strongly improves their immunogenicity. Mice immunized with lipidated proteins showed enhanced antibody concentrations and different induction kinetics. The induced humoral immune response was modulated by lipidation, indicated by increased IgG2/IgG1 subclass ratios related to Th1-type immunity. In a mouse model of colonization, immunization with lipidated antigens led to a moderate but consistent reduction of pneumococcal colonization as compared to the non-lipidated proteins, indicating that protein lipidation can improve the protective capacity of the coupled antigen. Thus, protein lipidation represents a promising approach for the development of a serotype-independent pneumococcal vaccine.

  • Voss, F.
  • van Beek, L. F.
  • Schwudke, D.
  • Ederveen, T. H. A.
  • van Opzeeland, F. J.
  • Thalheim, D.
  • Werner, S.
  • de Jonge, M. I.
  • Hammerschmidt, S.

Keywords

  • Streptococcus pneumoniae
  • immune response
  • lipidation
  • lipoproteins
  • pneumococcal colonization
  • protection
  • vaccine
Publication details
DOI: 10.3390/vaccines8020310
Journal: Vaccines (Basel)
Number: 2
Work Type: Original
Location: ARCN
Disease Area: PALI
Partner / Member: FZB
Access-Number: 32560374
See publication on PubMed

DZL Engagements

chevron-down